DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more


Nutrilib.com
A comprihensive source of nutritional information

Immunogenicity and Safety of the Concomitant Administration of a Tdap Vaccine and Meningococcal ACWY Conjugate Vaccine in Healthy Subjects Aged 11-25 Years

Information source: Novartis
Information obtained from ClinicalTrials.gov on 2006-11-30
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Meningococcal Disease; Meningococcal Meningitis

Intervention: Meningococcal ACWY conjugate vaccine (Vaccine)

Phase: Phase 3

Status: Recruiting. Expecting to enroll 1000 people.

Sponsored by: Novartis

Official(s) and/or principal investigator(s):
Novartis Vaccines - Information Services, Study Chair, Affiliation: Novartis Vaccines & Diagnostics

Overall contact:
Novartis Vaccines - Information Services, Phone: +1 800 2447668, Ext: press 2

Summary

Immunogenicity and Safety of the Concomitant Administration of a Tdap Vaccine and Meningococcal ACWY Conjugate Vaccine in Healthy Subjects Aged 11-25 Years

Clinical Details

Official title: A Phase 3, Multi-Center, Observer Blind, Controlled, Randomized Study to Compare the Immunogenicity and Safety of the Concomitant Administration of a Combined Tetanus, Reduced Diphtheria, and Acellular Pertussis (Tdap) Vaccine and Chiron Meningococcal ACWY Conjugate Vaccine, With Either One Dose of Acellular Pertussis (Tdap) Vaccine, Or One Dose of Chiron Meningococcal ACWY Conjugate Vaccine, in Healthy Subjects Aged 11-25 Years

Study design: Interventional, Prevention, Randomized, Single Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study

Primary outcome:

Secondary outcome:

Eligibility

Minimum age: 11 Years. Maximum age: 25 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Healthy subjects aged 11-25 years

Exclusion Criteria:

- previous ascertained or suspected disease caused by N. meningitidis

- previously been immunized with a meningococcal vaccine or vaccine containing meningococcal antigen(s)

- serious acute, chronic or progressive disease

Locations and Contacts

Novartis Vaccines - Information Services, Phone: +1 800 2447668, Ext: press 2

Genova-Pieve di Soligo-Massafra-, Ferrara- Chieti-Lanciano-Modena, Italy; Recruiting
Additional Information

Starting date: April 2006
Last updated: September 13, 2006

Page last updated: 2006-11-30

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008